Beurs gesloten -
OTC Markets
15:30:03 13-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
0,0001
USD
|
0,00%
|
|
0,00%
|
-94,74%
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
16,19
|
177,2
|
81,55
|
144,5
|
37,61
|
Bedrijfswaarde
1 |
16,02
|
181,9
|
89,35
|
164
|
65,37
|
K/w-verhouding
|
-103
x
|
-17,5
x
|
-7,53
x
|
-11,5
x
|
-1,2
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
11,6
x
|
35,9
x
|
10
x
|
6,59
x
|
1,73
x
|
Bedrijfswaarde/omzet
|
11,4
x
|
36,9
x
|
11
x
|
7,48
x
|
3
x
|
Bedrijfswaarde/EBITDA
|
-26,5
x
|
-44,6
x
|
-19,1
x
|
-37,4
x
|
-5,76
x
|
Bedrijfswaarde/FCF
|
-18.043.705
x
|
-25.207.697
x
|
44.338.309
x
|
-47.263.205
x
|
7.733.690
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
-0%
|
0%
|
Price to Book
|
47
x
|
23,8
x
|
10,5
x
|
1,75
x
|
0,62
x
|
Aantal aandelen (in duizenden)
|
7.361
|
63.515
|
54.365
|
90.910
|
95.213
|
Referentieprijs
2 |
2,200
|
2,790
|
1,500
|
1,590
|
0,3950
|
Datum van publicatie
|
27/06/19
|
14/01/20
|
12/01/21
|
13/01/22
|
13/01/23
|
Fiscaal tijdperk: September |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
0,2551
|
1,402
|
4,934
|
8,122
|
21,94
|
21,76
|
EBITDA
1 |
-0,3941
|
-0,604
|
-4,077
|
-4,688
|
-4,38
|
-11,35
|
Bedrijfsresultaat (EBIT)
1 |
-0,4357
|
-0,6538
|
-4,382
|
-5,326
|
-5,601
|
-13,12
|
Operationele Marge
|
-170,79%
|
-46,64%
|
-88,82%
|
-65,58%
|
-25,53%
|
-60,3%
|
Resultaat voor belastingen (EBT)
1 |
-0,4357
|
-0,6212
|
-9,949
|
-12,39
|
-10,91
|
-31,17
|
Nettowinst (verlies)
1 |
-0,4357
|
-0,6887
|
-9,825
|
-12,27
|
-10,91
|
-31,14
|
Nettomarge
|
-170,79%
|
-49,13%
|
-199,12%
|
-151,12%
|
-49,71%
|
-143,14%
|
WPA
2 |
-0,0579
|
-0,0213
|
-0,1597
|
-0,1992
|
-0,1388
|
-0,3300
|
Free Cash Flow
|
-
|
-0,8878
|
-7,218
|
2,015
|
-3,47
|
8,452
|
FCF-marge
|
-
|
-63,33%
|
-146,28%
|
24,81%
|
-15,82%
|
38,85%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
27/06/19
|
27/06/19
|
14/01/20
|
12/01/21
|
13/01/22
|
13/01/23
|
Fiscaal tijdperk: September |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
---|
Omzet
1 |
6,693
|
6,094
|
6,186
|
6,638
|
4,931
|
4,001
|
5,004
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-0,2473
|
-5,505
|
-2,135
|
-2,772
|
-3,848
|
-4,366
|
-1,585
|
Operationele Marge
|
-3,69%
|
-90,34%
|
-34,51%
|
-41,76%
|
-78,03%
|
-109,1%
|
-31,68%
|
Resultaat voor belastingen (EBT)
1 |
-0,8339
|
-9,046
|
-3,345
|
-3,869
|
-5,473
|
-18,48
|
-3,244
|
Nettowinst (verlies)
1 |
-0,8339
|
-9,046
|
-3,345
|
-3,878
|
-5,47
|
-18,45
|
-3,258
|
Nettomarge
|
-12,46%
|
-148,45%
|
-54,07%
|
-58,42%
|
-110,93%
|
-461,06%
|
-65,1%
|
WPA
2 |
-0,0100
|
-0,1100
|
-0,0400
|
-0,0400
|
-0,0600
|
-0,2000
|
-0,0300
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
16/08/21
|
13/01/22
|
14/02/22
|
16/05/22
|
15/08/22
|
13/01/23
|
14/02/23
|
Fiscaal tijdperk: September |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
-
|
-
|
4,73
|
7,8
|
19,5
|
27,8
|
Nettokaspositie
1 |
0,01
|
0,17
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-1,16
x
|
-1,664
x
|
-4,446
x
|
-2,446
x
|
Free Cash Flow
|
-
|
-0,89
|
-7,22
|
2,02
|
-3,47
|
8,45
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-40,2%
|
-201%
|
-160%
|
-23,2%
|
-42,1%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-13,5%
|
-28,1%
|
-18,9%
|
-5,09%
|
-7,21%
|
Totale activa
1 |
-
|
5,111
|
35,01
|
64,78
|
214,1
|
432,1
|
Nettoactief per aandeel
2 |
0,1300
|
0,0500
|
0,1200
|
0,1400
|
0,9100
|
0,6300
|
Cashflow per aandeel
2 |
0
|
0,0300
|
0
|
0
|
0,0200
|
0
|
Capex
|
-
|
0,34
|
6,01
|
0,17
|
2,24
|
4,33
|
Capex/omzet
|
-
|
24,27%
|
121,74%
|
2,06%
|
10,22%
|
19,89%
|
Datum van publicatie
|
27/06/19
|
27/06/19
|
14/01/20
|
12/01/21
|
13/01/22
|
13/01/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -94,74% | 70,19K | | -.--% | 339 mln. | | +40,21% | 289 mln. | | +42,80% | 280 mln. | | +44,19% | 188 mln. | | +156,53% | 146 mln. | | -37,59% | 129 mln. | | +11,54% | 97,22 mln. | | -28,57% | 121 mln. | | +10,34% | 57,54 mln. |
medicinale landbouw
|